Regulatory T Cells and Immune Tolerance

Cell

Volumn 133, Issue 5, 2008, Pages 775-787

  Sakaguchi, Shimon ^a,b,c   Yamaguchi, Tomoyuki ^a   Nomura, Takashi ^a   Ono, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN RECOGNITION; AUTOIMMUNITY; CELL MATURATION; CELL TRANSPORT; CELLULAR DISTRIBUTION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOPATHOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; THYMUS;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 43949105866     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2008.05.009     Document Type: Review

References (114)

1. Akiyama T., Maeda S., Yamane S., Ogino K., Kasai M., Kajiura F., Matsumoto M., and Inoue J. Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science 308 (2005) 248-251
2. Antony P.A., Paulos C.M., Ahmadzadeh M., Akpinarli A., Palmer D.C., Sato N., Kaiser A., Hinrichs C.S., Klebanoff C.A., Tagaya Y., and Restifo N.P. Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J. Immunol. 176 (2006) 5255-5266
3. Apostolou I., and von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199 (2004) 1401-1408
4. + regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nat. Immunol. 8 (2007) 351-358
5. Baecher-Allan C., Viglietta V., and Hafler D.A. Human CD4+CD25+ regulatory T cells. Semin. Immunol. 16 (2004) 89-98
6. Belkaid Y., and Rouse B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 6 (2005) 353-360
7. + regulatory T cells control Leishmania major persistence and immunity. Nature 420 (2002) 502-507
8. Benson M.J., Pino-Lagos K., Rosemblatt M., and Noelle R.J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204 (2007) 1765-1774
9. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., and Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
10. + regulatory T cells. J. Immunol. 177 (2006) 6603-6612
11. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., and Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27 (2001) 68-73
12. Burchill M.A., Yang J., Vogtenhuber C., Blazar B.R., and Farrar M.A. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178 (2007) 280-290
13. Cantor H., Shen F.W., and Boyse E.A. Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J. Exp. Med. 143 (1976) 1391-1400
14. Caudy A.A., Reddy S.T., Chatila T., Atkinson J.P., and Verbsky J.W. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J. Allergy Clin. Immunol. 119 (2007) 482-487
15. + T cell activation. Immunity 27 (2007) 625-634
16. Chen C., Rowell E.A., Thomas R.M., Hancock W.W., and Wells A.D. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J. Biol. Chem. 281 (2006) 36828-36834
17. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., and Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalitis. Science 265 (1994) 1237-1240
18. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
19. Cobb B.S., Hertweck A., Smith J., O'Connor E., Graf D., Cook T., Smale S.T., Sakaguchi S., Livesey F.J., Fisher A.G., and Merkenschlager M.A. A role for Dicer in immune regulation. J. Exp. Med. 203 (2006) 2519-2527
20. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., Cross R., Sehy D., Blumberg R.S., and Vignali D.A. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 (2007) 566-569
21. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204 (2007) 1757-1764
22. Danke N.A., Koelle D.M., Yee C., Beheray S., and Kwok W.W. Autoreactive T cells in healthy individuals. J. Immunol. 172 (2004) 5967-5972
23. + regulatory cell activation and function by dendritic cells. Int. Immunol. 16 (2004) 1769-1780
24. + regulatory T cells in the steady state. J. Exp. Med. 198 (2003) 737-746
25. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., Schlawe K., Chang H.D., Bopp T., Schmitt E., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5 (2007) e38 10.1371/journal.pbio.0050038
26. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
27. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6 (2005) 1142-1151
28. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177 (1993) 627-636
29. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., Ocheltree E.L., Greenberg P.D., Ochs H.D., and Rudensky A.Y. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103 (2006) 6659-6664
30. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., and Rudensky A.Y. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
31. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
32. Haribhai D., Lin W., Relland L.M., Truong N., Williams C.B., and Chatila T.A. Regulatory T cells dynamically control the primary immune response to foreign antigen. J. Immunol. 178 (2007) 2961-2972
33. Hill J.A., Feuerer M., Tash K., Haxhinasto S., Perez J., Melamed R., Mathis D., and Benoist C. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 27 (2007) 786-800
34. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., Yamaguchi T., Nomura T., Ito H., Nakamura T., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204 (2007) 2803-2812
35. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
36. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., and Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7 (2006) 401-410
37. Huehn J., and Hamann A. Homing to suppress: address codes for Treg migration. Trends Immunol. 26 (2005) 632-636
38. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F., and Sakaguchi S. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162 (1999) 5317-5326
39. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2 (2001) 301-306
40. Kajiura F., Sun S., Nomura T., Izumi K., Ueno T., Bando Y., Kuroda N., Han H., Li Y., Matsushima A., et al. NF-kappa B-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J. Immunol. 172 (2004) 2067-2075
41. + 'effector' regulatory T cells in the gravid uterus. Proc. Natl. Acad. Sci. USA 104 (2007) 594-599
42. + regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol. 168 (2002) 4399-4405
43. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4 (2003) 337-342
44. Kim J.M., Rasmussen J.P., and Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8 (2007) 191-197
45. Klein L., Khazaie K., and von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100 (2003) 8886-8891
46. + regulatory T cell development. J. Exp. Med. 203 (2006) 119-129
47. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6 (2005) 1219-1227
48. Lahl K., Loddenkemper C., Drouin C., Freyer J., Arnason J., Eberl G., Hamann A., Wagner H., Huehn J., and Sparwasser T. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204 (2007) 57-63
49. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., Blank R.B., Meylan F., Siegel R., Hennighausen L., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 (2007) 371-381
50. + T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201 (2005) 1037-1044
51. Li B., and Greene M.I. FOXP3 actively represses transcription by recruiting the HAT/HDAC complex. Cell Cycle 6 (2007) 1432-1436
52. Lin W., Haribhai D., Relland L.M., Truong N., Carlson M.R., Williams C.B., and Chatila T.A. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8 (2007) 359-368
53. Malek T.R., and Bayer A.L. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4 (2004) 665-674
54. Marson A., Kretschmer K., Frampton G.M., Jacobsen E.S., Polansky J.K., MacIsaac K.D., Levine S.S., Fraenkel E., von Boehmer H., and Young R.A. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445 (2007) 931-935
55. Mathis D., and Benoist C. A decade of AIRE. Nat. Rev. Immunol. 7 (2007) 645-650
56. - precursor cells in the absence of interleukin 10. Nat. Immunol. 8 (2007) 931-941
57. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16 (2002) 311-323
58. Miyara M., and Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13 (2007) 108-116
59. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., and Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317 (2007) 256-260
60. + helper T cell responses in cancer patients. Blood 106 (2005) 1008-1011
61. Ochs H.D., Ziegler S.F., and Torgerson T.R. FOXP3 acts as a rheostat of the immune response. Immunol. Rev. 203 (2005) 156-164
62. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., Miyachi Y., Tsukada T., and Sakaguchi S. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446 (2007) 685-689
63. + regulatory T cells. Immunity 27 (2007) 493-504
64. + T cells. Nat. Immunol. 8 (2007) 1353-1362
65. low subset. J. Exp. Med. 172 (1990) 1701-1708
66. Ranger A.M., Oukka M., Rengarajan J., and Glimcher L.H. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9 (1998) 627-635
67. Rao A., Luo C., and Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15 (1997) 707-747
68. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192 (2000) 295-302
69. Sakaguchi S. Animal models of autoimmunity and their relevance to human diseases. Curr. Opin. Immunol. 12 (2000) 684-690
70. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (2005) 345-352
71. Sakaguchi S., Takahashi T., and Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. 156 (1982) 1577-1586
72. Sakaguchi S., Fukuma K., Kuribayashi K., and Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T-cell subset. I. Evidence for the active participation of T cells in natural self-tolerance: deficit of a T-cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161 (1985) 72-87
73. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
74. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
75. + regulatory T cells in the regional lymph node. J. Exp. Med. 202 (2005) 771-781
76. + regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204 (2007) 1335-1347
77. Scheinecker C., McHugh R., Shevach E.M., and Germain R.N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196 (2002) 1079-1090
78. + regulatory T cells. J. Exp. Med. 204 (2007) 735-745
79. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201 (2005) 723-735
80. Shevach E.M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25 (2006) 195-201
81. + regulatory T cells. Immunol. Rev. 212 (2006) 60-73
82. + T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163 (1999) 5211-5218
83. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3 (2002) 135-142
84. Singh B., Read S., Asseman C., Malmstrom V., Mottet C., Stephens L.A., Stepankova R., Tlaskalova H., and Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182 (2001) 190-200
85. + regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc. Natl. Acad. Sci. USA 102 (2005) 17418-17423
86. + natural regulatory T cells revealed by DNA microarray analysis. Int. Immunol. 18 (2006) 1197-1209
87. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., and Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204 (2007) 1775-1785
88. Sutmuller R.P., Morgan M.E., Netea M.G., Grauer O., and Adema G.J. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol. 27 (2006) 387-393
89. Szanya V., Ermann J., Taylor C., Holness C., and Fathman C.G. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169 (2002) 2461-2465
90. + T cells and dendritic cells in vivo. J. Exp. Med. 203 (2006) 505-511
91. Tang Q., and Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9 (2008) 239-244
92. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10 (1998) 1969-1980
93. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192 (2000) 303-310
94. Tang Q., Adams J.Y., Tooley A.J., Bi M., Fife B.T., Serra P., Santamaria P., Locksley R.M., Krummel M.F., and Bluestone J.A. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7 (2006) 83-92
95. Taniuchi I., Osato M., Egawa T., Sunshine M.J., Bae S.C., Komori T., Ito Y., and Littman D.R. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111 (2002) 621-633
96. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188 (1998) 287-296
97. + T cells during cure of colitis. J. Immunol. 177 (2006) 5852-5860
98. van Santen H.M., Benoist C., and Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200 (2004) 1221-1230
99. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
100. Vieira P.L., Christensen J.R., Minaee S., O'Neill E.J., Barrat F.J., Boonstra A., Barthlott T., Stockinger B., Wraith D.C., and O'Garra A. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 172 (2004) 5986-5993
101. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6 (2005) 338-344
102. Waldmann H., Adams E., Fairchild P., and Cobbold S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 212 (2006) 301-313
103. Wan Y.Y., and Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445 (2007) 766-770
104. Wang H.Y., and Wang R.F. Regulatory T cells and cancer. Curr. Opin. Immunol. 19 (2007) 217-223
105. + regulatory T cells in human thymus. Nature 436 (2005) 1181-1185
106. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
107. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., Bates D.L., Guo L., Han A., Ziegler S.F., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
108. + regulatory T cells. Int. Immunol. 16 (2004) 1643-1656
109. Yamaguchi T., Hirota K., Nagahama K., Ohkawa K., Takahashi T., Nomura T., and Sakaguchi S. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27 (2007) 145-159
110. Yamanouchi J., Rainbow D., Serra P., Howlett S., Hunter K., Garner V.E., Gonzalez-Munoz A., Clark J., Veijola R., Cubbon R., et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39 (2007) 329-337
111. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198 (2003) 235-247
112. Yao Z., Kanno Y., Kerenyi M., Stephens G., Durant L., Watford W.T., Laurence A., Robinson G.W., Shevach E.M., Moriggl R., et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109 (2007) 4368-4375
113. + regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J. Exp. Med. 203 (2006) 2451-2460
114. Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., and Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445 (2007) 936-940